Human cells can detect physical cues far beyond the surfaces they touch, with normal epithelial cells probing up to 100 microns into surrounding tissue and cancer cells sensing 10 microns ahead, a new study has found. Researchers from Washington University in St. Louis say this long-range “depth mechano-sensing” helps cells decide where to move, potentially revealing ways to block cancer metastasis by disrupting tumour cells’ navigation.
The findings, published in the Proceedings of the National Academy of Sciences, challenge earlier views that such extended sensing was limited to unusual cells like those in tumours. Amit Pathak, a professor of mechanical engineering and materials science at the university’s school of engineering, led the work on how cells interact with the physical properties of their extracellular matrix. He explained that cells pull and reshape fibrous collagen around them to extend their reach and “feel” stiffness in deeper layers, such as tumours, soft tissue or bone.
This process guides cell migration by signalling the best direction forward. Pathak’s team previously showed that abnormal cells with strong front-rear polarity, typical of migrating ones, detect cues up to 10 microns, or one millionth of a metre, beyond their attachment points. Now, they demonstrate that groups of ordinary epithelial cells, which line skin and body cavities, achieve an even greater range through collective action.
“Because it’s a collective of cells, they are generating higher forces,” Pathak said. These forces allow epithelial clusters to deform collagen fibres enough to sense up to 100 microns deep, far surpassing individual cell limits.
Cancer cells exploit this ability to escape primary tumours, navigate surrounding tissue and evade immune detection during spread. Interfering with their mechano-sensing could limit metastasis, the researchers propose, offering a novel therapeutic target beyond traditional chemical signalling pathways. The study highlights how physical cues in the extracellular matrix influence cell behaviour, with implications for tissue engineering, wound healing and disease progression.
Pathak noted the sensing relies on cells actively remodelling their collagen environment to probe ahead. Stiffer substrates, like those in tumours, draw migrating cells toward them, promoting invasion. In normal tissues, collective sensing maintains structural integrity, but in cancer, it fuels uncontrolled movement.
The work builds on growing evidence that mechanical forces shape biology as much as genetics or biochemistry. Earlier studies linked matrix stiffness to cancer aggressiveness, but this research quantifies the depth of detection and its variation by cell type. Pathak’s group used advanced imaging and modelling to visualise how forces propagate through fibres, revealing collective amplification in healthy epithelia.
For oncology, the discovery suggests that drugs or biomaterials that soften the matrix or dampen force generation could trap cancer cells. Preclinical tests might target polarity proteins or collagen remodelling enzymes to blunt long-range probing. The team aims to explore these in animal models next.
This mechano-sensing insight comes amid rising focus on the tumour microenvironment’s role in metastasis, which causes 90 per cent of cancer deaths. Traditional therapies often fail against disseminated cells, making physical disruption a promising complement. Pathak’s findings position depth sensing as a key vulnerability for intervention.
